News Conference News VIVA 2025 ENGULF Novel PE Thrombectomy Device Minimizes Blood Loss L.A. McKeown November 07, 2025
News Conference News VIVA 2024 DETOUR 2: Endovascular Procedure That Mimics Femoral Bypass Durable at 3 Years L.A. McKeown November 11, 2024
News Conference News VIVA 2024 Amputations Still Avoided With Flow-Diverting Therapy for CLTI at 2 Years: PROMISE II L.A. McKeown November 06, 2024
News Conference News VIVA 2024 Disappearing Scaffold for CLTI Still Works Well at 2 Years: LIFE-BTK L.A. McKeown November 05, 2024
News Conference News VIVA 2023 New Carotid Stent Systems Associated With Low Stroke Risk L.A. McKeown November 09, 2023
News Conference News VIVA 2023 PROMISE II: Deep-Vein Arterialization Durable for Amputation-Free Survival in CLTI L.A. McKeown November 01, 2023
News Conference News VIVA 2021 EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions L.A. McKeown October 12, 2021
News Conference News VIVA 2020 DISRUPT PAD III: Lithotripsy Shows Promise in Heavily Calcified PAD L.A. McKeown November 09, 2020
News Conference News VIVA 2019 Nearly 1 Year Later, Endovascular Community Continues to Struggle With Paclitaxel L.A. McKeown November 08, 2019
News Conference News VIVA 2018 IMPERIAL Substudy Provides Reassurance for Benefit of Eluvia in Long Lesions L.A. McKeown November 06, 2018
News Conference News VIVA 2017 ACT I: Women Reap More Long-term Benefits From Carotid Stenting vs CEA L.A. McKeown September 15, 2017
News Conference News VIVA 2017 EVAR Outcomes Equivalent Between Men and Women, Registries Show L.A. McKeown September 14, 2017
News Conference News VIVA 2016 Longer Term, IN.PACT SFA Trial and Global Registry Continue to Support DCB Therapy as an Option L.A. McKeown October 12, 2016
News Conference News VIVA 2016 Long PAD Lesions Respond Well to DCB, but Optimal Patient Selection Still Unclear L.A. McKeown September 21, 2016